NATCOPHARM - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Technical Rating: 3.6

Here’s a detailed technical analysis of Natco Pharma Ltd (NATCOPHARM)

📊 Trend Overview

Current Trend: Mild recovery within a broader downtrend

Price is trading below the 200 DMA (₹1,013) but above the 50 DMA (₹942), suggesting short-term strength but long-term weakness.

The stock is far from its 52-week high (₹1,639), reflecting a significant correction and low momentum.

📈 Momentum Indicators

RSI (48.2): Neutral zone, slightly bearish. No clear overbought/oversold signal.

MACD (16.0): Positive, indicating short-term bullish momentum.

Volume: Below weekly average, suggesting weak conviction behind recent price moves.

📉 Moving Averages & Chart Patterns

Support Levels

₹942 (50 DMA, immediate support)

₹900 (psychological support)

₹850 (trendline support)

Resistance Levels

₹980–₹1,000 (minor resistance zone)

₹1,013 (200 DMA, major resistance)

₹1,100+ (breakout territory)

📎 Bollinger Bands

Price is near the middle band, with narrowing bands indicating low volatility.

No breakout signals; consolidation likely unless volume picks up.

🔍 Short-Term Signals

Momentum: Mixed. MACD is bullish, but RSI and volume are weak.

Entry Zone: ₹940–₹955 (on pullback near 50 DMA)

Exit Zone: ₹980–₹1,010 (near resistance or MACD peak)

🧭 Conclusion

Trend: Consolidating with mild bullish bias.

Outlook: Watch for breakout above ₹1,013 or breakdown below ₹942.

Strategy: Cautious accumulation near ₹950 with tight stop-loss. Avoid aggressive buying until volume and RSI improve.

Would you like a visual chart or a comparison with another pharma stock like Divi’s or Sun Pharma?

Edit in a page